Provided by Tiger Fintech (Singapore) Pte. Ltd.

Amgen

288.41
-5.3100-1.81%
Volume:785.06K
Turnover:227.44M
Market Cap:155.27B
PE:23.58
High:294.60
Open:292.61
Low:287.56
Close:293.72
52wk High:339.17
52wk Low:253.30
Shares:538.36M
Float Shares:536.99M
Volume Ratio:0.48
T/O Rate:0.15%
Dividend:9.26
Dividend Rate:3.21%
EPS(TTM):12.23
EPS(LYR):7.62
ROE:99.14%
ROA:7.51%
PB:20.90
PE(LYR):37.87

Loading ...

Amgen Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Aug 19

UnitedHealth, Salesforce Share Gains Contribute To Dow's 213-Point Climb

Dow Jones
·
Aug 15

Daiwa Securities Adjusts Price Target on Amgen to $310 From $350, Maintains Outperform Rating

MT Newswires Live
·
Aug 15

Amgen (AMGN) Gets a Buy from Bernstein

TIPRANKS
·
Aug 15

Amgen Inc : Bernstein Cuts Target Price to $335 From $350

THOMSON REUTERS
·
Aug 14

Cantor Fitzgerald Reaffirms Their Hold Rating on Amgen (AMGN)

TIPRANKS
·
Aug 14

Amgen’s Pediatric SHPT Study: A Potential Game-Changer for Etelcalcetide

TIPRANKS
·
Aug 14

Zevra Reported Its First-Ever Quarterly Profit. Why Shares Of The Top 6% Stock Crashed.

Blockhead
·
Aug 13

Bernstein Adjusts Price Target on Amgen to $335 From $350

MT Newswires Live
·
Aug 13

BUZZ-Bernstein cuts PT on Amgen citing MariTide risk

Reuters
·
Aug 13

TScan Therapeutics Q2 2025 Results: Revenue Surges to $3.1M, Net Loss Widens to $37M

Reuters
·
Aug 12

Piper Sandler Reaffirms Their Buy Rating on Amgen (AMGN)

TIPRANKS
·
Aug 12

Amgen Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
Aug 12

Amgen Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
Aug 09

Amgen’s Promising Study on Romosozumab for Osteogenesis Imperfecta

TIPRANKS
·
Aug 09

Amgen price target raised to $272 from $261 at BofA

TIPRANKS
·
Aug 08

Amgen’s Promising Cardiovascular Study: A Potential Game-Changer?

TIPRANKS
·
Aug 08

Amgen’s Promising Phase 3 Study on Dazodalibep for Sjögren’s Syndrome

TIPRANKS
·
Aug 08

HSBC Adjusts Amgen Price Target to $343 From $337, Maintains Buy Rating

MT Newswires Live
·
Aug 07

Leerink Partners Remains a Hold on Amgen (AMGN)

TIPRANKS
·
Aug 07